AsCNP/JSNP/JSCNP 2019

Presentation information

[AsCNP] Poster Session

AsCNP » [AsCNP] Poster Session

[AsCNP_P12] Poster Session 12
Depression 6

Sun. Oct 13, 2019 4:40 PM - 6:10 PM Poster Hall (Multi-purpose Hall)

Chair: ‌Yu OHMURA (Department of Neuropharmacology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan)

4:55 PM - 5:00 PM

[AsCNP-P12-4] Possible involvement of AKT-GSK3β signal-upregulated MEF2D protein in imipramine-enhanced the expression of astrocytic interleukin-10 under inflammatory state

Yosuke YAMAWAKI1, 2, Satomi SHIRAWACHI2, Munechika TAKAISHI2, Shigeto YAMAWAKI3, Takashi KANEMATSU2, 4 (1. Department of Advanced Pharmacology, Daiichi University of Pharmacy, Fukuoka, Japan, 2. Department of Cellular and Molecular Pharmacology Institute of Biomedical and Health Sciences Hiroshima University, Hiroshima, Japan, 3. Office of Industry-Academia-Government and Community Collaboration Institute of Biomedical and Health Sciences Hiroshima Univesity, Hiroshima, Japan, 4. Department of Cell Biology and Pharmacology, Faculty of Dental Science, Kyushu University, Fukuoka, Japan)

Abstract password authentication.
Password to browse/download the abstracts has been sent to pre-registrants by email and printed on name badge. It is also indicated in the abstract booklet.

Password